NDC 72934-1022

BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.025%

Benzoyl Peroxide 2.5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.025%

BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.025% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Tretinoin; Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide.

Product ID72934-1022_897e88a9-c011-22f1-e053-2a95a90afdb2
NDC72934-1022
Product TypeHuman Prescription Drug
Proprietary NameBENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.025%
Generic NameBenzoyl Peroxide 2.5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.025%
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2019-05-22
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameTRETINOIN; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE; NIACINAMIDE
Active Ingredient Strength0 g/100g; g/100g; g/100g; g/100g
Pharm ClassesRetinoid [EPC],Retinoids [CS],Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-1022-2

30 g in 1 BOTTLE, PUMP (72934-1022-2)
Marketing Start Date2019-05-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-1022-2 [72934102202]

BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.025% GEL
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2019-05-22

Drug Details

Active Ingredients

IngredientStrength
TRETINOIN.025 g/100g

OpenFDA Data

SPL SET ID:897e88a9-c010-22f1-e053-2a95a90afdb2
Manufacturer
UNII

Pharmacological Class

  • Retinoid [EPC]
  • Retinoids [CS]
  • Decreased Sebaceous Gland Activity [PE]
  • Lincosamide Antibacterial [EPC]
  • Lincosamides [CS]
  • Retinoid [EPC]
  • Retinoids [CS]
  • Decreased Sebaceous Gland Activity [PE]
  • Lincosamide Antibacterial [EPC]
  • Lincosamides [CS]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.